Cost effectiveness and cost utility of the noncoding blood glucose meter CONTOUR® TS
Przemyslaw Holko, Pawal KawalecHTA Centre, Kraków, PolandAims: This study assessed the cost efficacy and cost utility of the automatic blood glucose meter CONTOUR® TS from the public payer (National Health Fund [NHF]) and payer (patient and NHF) perspectives over a 26-year...
Main Authors: | Przemyslaw Holko, Pawal Kawalec |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-02-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity |
Online Access: | http://www.dovepress.com/cost-effectiveness-and-cost-utility-of-the-noncoding-blood-glucose-met-a6293 |
Similar Items
-
Pharmacoeconomic analysis of blood glucose meter Contour TS in diabetes treatment
by: A. U. Kulikov, et al.
Published: (2015-03-01) -
Design of cost-efficient Glucose meter
by: Rao Sanjana, et al.
Published: (2021-01-01) -
Health-Related Quality of Life Impairment and Indirect Cost of Crohn's Disease: A Self-Report Study in Poland.
by: Przemysław Holko, et al.
Published: (2016-01-01) -
Central aortic blood pressure and augmentation index: comparison between Vasotens® and SphygmoCor® technology
by: Rogoza AN, et al.
Published: (2012-05-01) -
Asthma patients prefer Respimat® Soft Mist™ Inhaler to Turbuhaler®
by: Rick Hodder, et al.
Published: (2009-05-01)